METIPRENALINE

ID: ALA2074647

Max Phase: Phase

Molecular Formula: C12H19NO3

Molecular Weight: 225.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(C(O)CNC(C)C)ccc1O

Standard InChI:  InChI=1S/C12H19NO3/c1-8(2)13-7-11(15)9-4-5-10(14)12(6-9)16-3/h4-6,8,11,13-15H,7H2,1-3H3

Standard InChI Key:  XXCCGRRUBBGZRE-UHFFFAOYSA-N

Associated Targets(Human)

Solute carrier family 22 member 3 143 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Solute carrier family 22 member 1 646 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Solute carrier family 22 member 2 261 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Solute carrier family 22 member 1 176 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Solute carrier family 22 member 2 136 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 225.29Molecular Weight (Monoisotopic): 225.1365AlogP: 1.43#Rotatable Bonds: 5
Polar Surface Area: 61.72Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.11CX Basic pKa: 9.36CX LogP: 0.74CX LogD: -0.90
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.71Np Likeness Score: 0.37

References

1. Martel F, Vetter T, Russ H, Gründemann D, Azevedo I, Koepsell H, Schömig E..  (1996)  Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1.,  354  (1): [PMID:8878062] [10.1007/bf00171063]
2. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H..  (1994)  Drug excretion mediated by a new prototype of polyspecific transporter.,  372  (1): [PMID:7990927] [10.1038/372549a0]
3. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H..  (1997)  Cloning and characterization of two human polyspecific organic cation transporters.,  16  (1): [PMID:9260930] [10.1089/dna.1997.16.871]
4. Gründemann D, Köster S, Kiefer N, Breidert T, Engelhardt M, Spitzenberger F, Obermüller N, Schömig E..  (1998)  Transport of monoamine transmitters by the organic cation transporter type 2, OCT2.,  273  (1): [PMID:9812985] [10.1074/jbc.273.47.30915]
5. Arndt P, Volk C, Gorboulev V, Budiman T, Popp C, Ulzheimer-Teuber I, Akhoundova A, Koppatz S, Bamberg E, Nagel G, Koepsell H..  (2001)  Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1.,  281  (1): [PMID:11502595] [10.1152/ajprenal.2001.281.3.f454]
6. Hayer-Zillgen M, Brüss M, Bönisch H..  (2002)  Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.,  136  (1): [PMID:12110607] [10.1038/sj.bjp.0704785]
7. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date,